Abstract
Antimicrobial resistance is a healthcare problem of increasing significance, and there is increasing interest in developing new tools to address bacterial infections. Bacteria-targeting nanoparticles hold promise to improve drug efficacy, compliance, and safety. In addition, nanoparticles can also be used for novel applications, such as bacterial imaging or bioseperations. We here present the use of a scalable block-copolymer-directed self-assembly process, Flash NanoPrecipitation, to form zinc(II)-bis(dipicolylamine) modified nanoparticles that bind to both Gram-positive and Gram-negative bacteria with specificity. Particles have tunable surface ligand densities that change particle avidity and binding efficacy. A variety of materials can be encapsulated into the core of the particles, such as optical dyes or iron oxide colloids, to produce imageable and magnetically active bacterial targeting constructs. As a proof-of-concept, these particles are used to bind and separate bacteria from solution in a magnetic column. Magnetic manipulation and separation would translate to a platform for pathogen identification or removal. These magnetic and targeted nanoparticles enable new methods to address bacterial infections.
Highlights
Bacterial infections are major contributors to morbidity and have become increasingly difficult to manage due to the emergence of antimicrobial resistance
NPs loaded with Ettp5 fluorophore were formed with ZnDPA surface functionalization at 0, 6.3, 13, 25, 50, 75, and 100% using Flash NanoPrecipitation (FNP)
These NPs were formed by changing the blends of PS-b-Polyethylene glycol (PEG)/PS-b-PEG-ZnDPA used during NP assembly (Fig. 1, Table S1)
Summary
Bacterial infections are major contributors to morbidity and have become increasingly difficult to manage due to the emergence of antimicrobial resistance. Keywords Nanoparticle Á Targeting Á Bacteria Á Filtering Á Antimicrobial resistance Á Magnetic separations Recent novel uses of targeted NPs include the binding and magnetic separation of bacteria from solution to treat bacterial sepsis, by passing NPs through custom-made microfluidic devices (Lee et al 2014).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.